Tinea Cruris

Tinea cruris, commonly known as

jock itch

, is a superficial fungal infection caused by dermatophytes affecting the groin, pubic region, and adjacent thighs. This condition thrives in warm, moist environments, leading to an itchy, erythematous rash that can significantly impact quality of life if untreated.

Introduction

**Tinea cruris** represents a dermatophyte infection specifically targeting intertriginous areas of the inguinal folds, perineum, and perianal region. Dermatophytes are keratinophilic fungi that invade the stratum corneum, hair, and nails, producing a characteristic annular rash with scaling and inflammation. The infection is more prevalent in males due to anatomical factors but can affect anyone in humid climates or with predisposing risk factors.

Globally, tinea cruris accounts for a substantial portion of superficial mycoses consultations. Its asymmetrical presentation and tendency to spare the scrotum distinguish it clinically. Early recognition and appropriate management are crucial to prevent chronicity and complications.

Demographics

Tinea cruris predominantly affects adult males, particularly those aged 20-50 years, with a higher incidence in tropical and subtropical regions. Risk is elevated among athletes, obese individuals, and those engaging in activities promoting sweating, such as sports or manual labor.

• Male-to-female ratio: Approximately 3:1, attributed to tighter clothing and scrotal involvement being less common in women.
• Geographic prevalence: Higher in humid climates; up to 20-30% of dermatology consultations in endemic areas.
• Age distribution: Rare in prepubertal children; peaks in young adulthood.
• Socioeconomic factors: More common in lower socioeconomic groups due to shared facilities and hygiene challenges.

Causes

The primary causative agents are anthropophilic dermatophytes, with

Trichophyton rubrum

being the most frequent isolate worldwide (50-90% of cases), followed by

Epidermophyton floccosum

and

Trichophyton mentagrophytes

complex. Zoophilic species like

Trichophyton verrucosum

are less common but more inflammatory.

Infection typically spreads autogenously from distant sites such as tinea pedis (athlete’s foot) via contaminated hands, towels, or clothing. Direct person-to-person transmission occurs in communal settings like locker rooms. Fungi proliferate in occluded, macerated skin with elevated pH.

Risk Factors

• Excessive sweating (hyperhidrosis)
• Tight, occlusive clothing (e.g., synthetic underwear)
• Obesity and diabetes mellitus
• Immunosuppression (HIV, corticosteroids)
• Concurrent tinea pedis or onychomycosis
• Poor hygiene and shared facilities

Clinical Features

The hallmark is an

erythematous, annular plaque

with a scaly, raised advancing border and central clearing, originating in the inguinal crease and extending to the inner thighs, rarely crossing the midline or involving the scrotum.

Symptoms include intense pruritus, burning, and stinging, exacerbated by sweating or friction. Acute lesions are bright red and vesiculopustular; chronic forms show hyperpigmentation and lichenification.

Key Clinical Characteristics of Tinea Cruris

Feature	Description
Shape	Annular with trailing scale
Color	Erythematous border, paler center
Symptoms	Itch, burn; pustules possible
Distribution	Unilateral/bilateral groin, spares scrotum

Complications

Untreated tinea cruris can lead to secondary bacterial superinfection, chronic lichenified plaques, and rarely

Majocchi’s granuloma

—a deep follicular invasion causing nodular lesions. Misuse of topical steroids may induce tinea incognito, masking the fungal etiology and promoting dissemination.

• Cellulitis from scratching
• Post-inflammatory hyperpigmentation
• Recurrent episodes eroding quality of life
• Dermatophytid (id) reactions—distant eczematous flares

Diagnosis

Diagnosis is primarily clinical but confirmed by

KOH microscopy

revealing hyphae or fungal culture/skin scraping PCR. Wood’s lamp may fluoresce green with Microsporum species (rare).

1. History: Itch, risk factors, tinea elsewhere
2. Examination: Annular scaly plaques
3. Microscopy: 10-20% KOH prep showing septate hyphae
4. Culture: Sabouraud agar for speciation (if resistant)
5. Biopsy: Rarely for atypical cases

Differential Diagnoses

Differential Diagnosis of Groin Rash

Condition	Key Distinguishing Features
Candidiasis	Satellite pustules, beefy red, no central clearing
Erythrasma	Coral-red Wood’s lamp fluorescence, no scale
Psoriasis	Symmetrical, nail pits, extensor involvement
Seborrhoeic dermatitis	Greasy scales, central face involvement
Contact dermatitis	Irregular borders, allergen history
Intertrigo	Bacterial overgrowth, foul odor

Treatment

Topical antifungals are first-line for localized disease, with

allylamines

(terbinafine 1% cream BID x2 weeks) superior to azoles due to fungicidal action and shorter duration. Azoles (clotrimazole, miconazole) are alternatives.

Topical Therapy

• Terbinafine/butenafine: 1-2 weeks, highest cure rates
• Azoles: 2-4 weeks
• Extend 1-2 cm beyond lesion; continue 1 week post-clearing

Systemic Therapy

Indicated for extensive, recalcitrant, or immunocompromised cases.

Oral Antifungals for Tinea Cruris

Agent	Dose	Duration	Notes
Terbinafine	250 mg daily	2 weeks	First-line; monitor LFTs
Fluconazole	150-200 mg weekly	2-4 weeks	Alternative
Itraconazole	200 mg daily	1 week	Short course

Avoid combination steroid-antifungals long-term due to atrophy risk; nystatin ineffective against dermatophytes.

Adjunctive Measures

• Keep dry: Absorbent powders (talc-free)
• Loose cotton underwear
• Treat concurrent tinea pedis
• Hygiene: Daily showers, dry thoroughly

Outcome

With appropriate therapy, cure rates exceed 80-90% within 2-4 weeks. Recurrence occurs in 20-50% without prevention; patient education is key. Monitor diabetics and immunocompromised for dissemination.

Frequently Asked Questions (FAQs)

Q: Is tinea cruris contagious?

A: Yes, via direct contact or fomites; avoid sharing towels.

Q: Can I use over-the-counter creams?

A: Yes, terbinafine or clotrimazole for mild cases; see doctor if no improvement in 2 weeks.

Q: How long until symptoms resolve?

A: 1-4 weeks with treatment; continue therapy post-resolution.

Q: Does jock itch affect women?

A: Less commonly, but possible in perineal folds.

Q: Can steroids treat jock itch?

A: No, they worsen it; use antifungals only.